Sound Income Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Buy |
470
+2
| +0.4% | +$890 | 0.01% | 272 |
|
|
2025
Q1 | $227K | Hold |
468
| – | – | 0.01% | 264 |
|
|
2024
Q4 | $188K | Hold |
468
| – | – | 0.01% | 261 |
|
|
2024
Q3 | $218K | Hold |
468
| – | – | 0.01% | 236 |
|
|
2024
Q2 | $219K | Hold |
468
| – | – | 0.01% | 214 |
|
|
2024
Q1 | $196K | Hold |
468
| – | – | 0.01% | 222 |
|
|
2023
Q4 | $190K | Buy |
468
+72
| +18% | +$29.3K | 0.02% | 198 |
|
|
2023
Q3 | $138K | Hold |
396
| – | – | 0.01% | 176 |
|
|
2023
Q2 | $139K | Sell |
396
-11
| -3% | -$3.87K | 0.01% | 180 |
|
|
2023
Q1 | $128K | Buy |
407
+11
| +3% | +$3.47K | 0.01% | 176 |
|
|
2022
Q4 | $114K | Buy |
396
+384
| +3,200% | +$111K | 0.01% | 183 |
|
|
2022
Q3 | $3K | Buy |
12
+4
| +50% | +$1K | ﹤0.01% | 667 |
|
|
2022
Q2 | $2K | Hold |
8
| – | – | ﹤0.01% | 759 |
|
|
2022
Q1 | $2K | Buy |
8
+2
| +33% | +$500 | ﹤0.01% | 751 |
|
|
2021
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 813 |
|
|
2021
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 792 |
|
|
2021
Q2 | $1K | Sell |
6
-5
| -45% | -$833 | ﹤0.01% | 842 |
|
|
2021
Q1 | $2.36K | Buy |
11
+5
| +83% | +$1.08K | ﹤0.01% | 739 |
|
|
2020
Q4 | $1K | Sell |
6
-13
| -68% | -$2.17K | ﹤0.01% | 830 |
|
|
2020
Q3 | $5K | Buy |
19
+6
| +46% | +$1.58K | ﹤0.01% | 549 |
|
|
2020
Q2 | $4K | Buy |
+13
| New | +$4K | ﹤0.01% | 551 |
|
|
2019
Q1 | – | Sell |
-5
| Closed | -$1K | – | 803 |
|
|
2018
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 632 |
|
|
2018
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 655 |
|